HealthNovartis Drug Fails Key Test of New Approach to Heart Disease

A Novartis drug considered a potential blockbuster failed to lower the risk of heart attacks and strokes in a final-stage trial, dealing a major setback to a new strategy for preventing cardiovascular disease.

Novartisheart diseaseclinical trial

BBloomberg News★★★☆☆2026-09-05 01:00Original